Related Experiment Video
Updated: Sep 22, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Dangerous RNA links pave the way to glioblastoma
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, 17165, Sweden; Science for Life Laboratory, Solna, 17165, Sweden; Human Technopole, via Rita Levi Montalcini 1, Milan, 20157, Italy.
Abstract:
A new study by Deforzh et al. (2022) demonstrates how two long non-coding RNAs (lncRNAs) link a distal enhancer to the HOXD3/D4/miR-10b gene promoter, leading to transcriptional activation of the therapeutic target miR-10b in glioblastoma multiforme.
Insights
Two long non-coding RNAs (lncRNAs) were found to activate the therapeutic target miR-10b in glioblastoma. This discovery reveals a novel mechanism for transcriptional activation in cancer.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Glioblastoma multiforme is an aggressive brain tumor with limited therapeutic options.
- Long non-coding RNAs (lncRNAs) play critical roles in gene regulation and cancer development.
- Understanding gene regulatory mechanisms is crucial for developing targeted therapies.
Purpose of the Study:
- To elucidate the mechanism by which lncRNAs regulate the HOXD3/D4/miR-10b gene cluster in glioblastoma.
- To identify potential therapeutic targets within this regulatory pathway.
Main Methods:
- The study utilized molecular biology techniques to investigate the interaction between lncRNAs and the HOXD3/D4/miR-10b gene promoter.
- Chromatin conformation capture and gene expression analysis were employed.
Main Results:
- Two specific lncRNAs were identified as crucial mediators.
- These lncRNAs were shown to physically link a distal enhancer region to the HOXD3/D4/miR-10b gene promoter.
- This interaction resulted in the transcriptional activation of miR-10b.
Conclusions:
- The findings reveal a novel mechanism of transcriptional regulation involving lncRNAs in glioblastoma.
- miR-10b is identified as a key therapeutic target activated by this lncRNA-mediated enhancer-promoter interaction.
- This study provides new insights into glioblastoma pathogenesis and potential therapeutic strategies.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
Leaky Scanning
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Non-LTR Retrotransposons

